This simple, unifying mechanism is also supported by the observation that highly specific inhibitors that target the acetyl binding pocket of BRD4 disrupt activation of some MLL-FP target genes such as MYC, and impair the growth of a wide range of different MLL-FP-mediated leukemias [185,186]. Here, BRD4 is linked to leukemia.